|
1
|
Makhov P, Joshi S, Ghatalia P, Kutikov A,
Uzzo RG and Kolenko VM: Resistance to systemic therapies in clear
cell renal cell carcinoma: Mechanisms and management strategies.
Mol Cancer Ther. 17:1355–1364. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Peri S, Devarajan K, Yang DH, Knudson AG
and Balachandran S: Meta-analysis identifies NF-κB as a therapeutic
target in renal cancer. PLoS One. 8:e767462013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Morais C, Gobe G, Johnson DW and Healy H:
The emerging role of nuclear factor kappa B in renal cell
carcinoma. Int J Biochem Cell Biol. 43:1537–1549. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Muglia VF and Prando A: Renal cell
carcinoma: Histological classification and correlation with imaging
findings. Radiol Bras. 48:166–174. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Aguilar-Alonso FA, Solano JD,
Vargas-Olvera CY, Pacheco-Bernal I, Pariente-Pérez TO and
Ibarra-Rubio ME: MAPKs' status at early stages of renal
carcinogenesis and tumors induced by ferric nitrilotriacetate. Mol
Cell Biochem. 404:161–170. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vargas-Olvera CY, Sánchez-González DJ,
Solano JD, Aguilar-Alonso FA, Montalvo-Muñoz F, Martínez-Martínez
CM, Medina-Campos ON and Ibarra-Rubio ME: Characterization of
N-diethylnitrosamine-initiated and ferric
nitrilotriacetate-promoted renal cell carcinoma experimental model
and effect of a tamarind seed extract against acute nephrotoxicity
and carcinogenesis. Mol Cell Biochem. 369:105–117. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mitchell S, Vargas J and Hoffmann A:
Signaling via the NFκB system. Wiley Interdiscip Rev Syst Biol Med.
8:227–241. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hayden MS and Ghosh S: Regulation of NF-κB
by TNF family cytokines. Semin Immunol. 26:253–266. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Desterro JM, Rodriguez MS and Hay RT:
SUMO-1 modification of IκBα inhibits NF-kappaB activation. Mol
Cell. 2:233–239. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Renard P, Percherancier Y, Kroll M, Thomas
D, Virelizier JL, Arenzana F and Bachelerie F: Inducible NF-kappaB
activation is permitted by simultaneous degradation of nuclear
IkappaBalpha. J Biol Chem. 275:15193–15199. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lua J, Qayyum T, Edwards J and Roseweir
AK: The prognostic role of the non-canonical nuclear factor-kappa B
pathway in renal cell carcinoma patients. Urol Int. 101:190–196.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Meteoglu I, Erdogdu IH, Meydan N, Erkus M
and Barutca S: NF-kappaB expression correlates with apoptosis and
angiogenesis in clear cell renal cell carcinoma tissues. J Exp Clin
Cancer Res. 27:532008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Morais C, Pat B, Gobe G, Johnson DW and
Healy H: Pyrrolidine dithiocarbamate exerts anti-proliferative and
pro-apoptotic effects in renal cell carcinoma cell lines. Nephrol
Dial Transplant. 21:3377–3388. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Oya M, Takayanagi A, Horiguchi A, Mizuno
R, Ohtsubo M, Marumo K, Shimizu N and Murai M: Increased nuclear
factor-κB activation is related to the tumor development of renal
cell carcinoma. Carcinogenesis. 24:377–384. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sourbier C, Danilin S, Lindner V, Steger
J, Rothhut S, Meyer N, Jacqmin D, Helwig JJ, Lang H and Massfelder
T: Targeting the nuclear factor-κB rescue pathway has promising
future in human renal cell carcinoma therapy. Cancer Res.
67:11668–11676. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Đorđević G, Matušan-Ilijaš K, Sinožić E,
Damante G, Fabbro D, Grahovac B, Lučin K and Jonjić N: Relationship
between vascular endothelial growth factor and nuclear factor-κB in
renal cell tumors. Croat Med J. 49:608–617. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
An J and Rettig MB: Epidermal growth
factor receptor inhibition sensitizes renal cell carcinoma cells to
the cytotoxic effects of bortezomib. Mol Cancer Ther. 6:61–69.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Oka D, Nishimura K, Shiba M, Nakai Y, Arai
Y, Nakayama M, Takayama H, Inoue H, Okuyama A and Nonomura N:
Sesquiterpene lactone parthenolide suppresses tumor growth in a
xenograft model of renal cell carcinoma by inhibiting the
activation of NF-kappaB. Int J Cancer. 120:2576–2581. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ng KL, Yap NY, Rajandram R, Small D,
Pailoor J, Ong TA, Razack AH, Wood ST, Morais C and Gobe GC:
Nuclear factor-kappa B subunits and their prognostic
cancer-specific survival value in renal cell carcinoma patients.
Pathology. 50:511–518. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Thornburg NJ and Raab-Traub N: Induction
of epidermal growth factor receptor expression by Epstein-barr
virus latent membrane protein 1 C-terminal-activating region 1 is
mediated by NF-κB p50 Homodimer/Bcl-3 complexes. J Virol.
81:12954–12961. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Staruschenko A, Palygin O, Ilatovskaya DV
and Pavlov TS: Epidermal growth factors in the kidney and
relationship to hypertension. Am J Physiol Renal Physiol.
305:F12–F20. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zeng F, Singh AB and Harris RC: The role
of the EGF family of ligands and receptors in renal development,
physiology and pathophysiology. Exp Cell Res. 315:602–610. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cohen D, Lane B, Jin T, Magi-Galluzzi C,
Finke J, Rini BI, Bukowski RM and Zhou M: The prognostic
significance of epidermal growth factor receptor expressionin
Clear-cell renal cell carcinoma: A call for standardized methods
for immunohistochemical evaluation. Clin Genitourinary Cancer.
5:264–270. 2007. View Article : Google Scholar
|
|
24
|
Kallio JP, Hirvikoski P, Helin H,
Kellokumpu-Lehtinen P, Luukkaala T, Tammela TL and Martikainen PM:
Membranous location of EGFR immunostaining is associated with good
prognosis in renal cell carcinoma. Br J Cancer. 89:1266–1269. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kankaya D, Kiremitci S, Tulunay O and
Baltaci S: Prognostic impact of epidermal growth factor receptor on
clear cell renal cell carcinoma: Does it change with different
expression patterns? Indian J Pathol Microbiol. 59:35–40.
2016.PubMed/NCBI
|
|
26
|
Merseburger AS, Hennenlotter J, Simon P,
Kruck S, Koch E, Horstmann M, Kuehs U, Küfer R, Stenzl A and Kuczyk
MA: Membranous expression and prognostic implications of epidermal
growth factor receptor protein in human renal cell cancer.
Anticancer Res. 25:1901–1907. 2005.PubMed/NCBI
|
|
27
|
Mock H, Sauter G, Buchholz N, Gasser TC,
Bubendorf L, Waldman FM and Mihatsch MJ: Epidermal growth factor
receptor expression is associated with rapid tumor cell
proliferation in renal cell carcinoma. Hum Pathol. 28:1255–1259.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pu YS, Huang CY, Kuo YZ, Kang WY, Liu GY,
Huang AM, Yu HJ, Lai MK, Huang SP, Wu WJ, et al: Characterization
of membranous and cytoplasmic EGFR expression in human normal renal
cortex and renal cell carcinoma. J Biomed Sci. 16:82. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Athar M and Iqbal M: Ferric
nitrilotriacetate promotes N-diethylnitrosamine-induced renal
tumorigenesis in the rat: Implications for the involvement of
oxidative stress. Carcinogenesis. 19:1133–1139. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ebina Y, Okada S, Hamazaki S, Ogino F, Li
JL and Midorikawa O: Nephrotoxicity and renal cell carcinoma after
use of Iron- and aluminum-nitrilotriacetate complexes in Rats2. J
Natl Cancer Inst. 76:107–113. 1986.PubMed/NCBI
|
|
31
|
Jahangir T and Sultana S: Modulatory
effects of shape pluchea lanceolata against chemically induced
oxidative damage, hyperproliferation and Two-stage renal
carcinogenesis in wistar rats. Mol Cell Biochem. 291:175–185. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mendoza-Rodrıguez CA, Monroy-Mendoza MG,
Morimoto S and Cerbón MA: Pro-apoptotic signals of the bcl-2 gene
family in the rat uterus occurs in the night before the day of
estrus and precedes ovulation. Mol Cell Endocrinol. 208:31–39.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schneider CA, Rasband WS and Eliceiri KW:
NIH image to ImageJ: 25 years of image analysis. Nat Methods.
9:671–675. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ledeganck KJ, Boulet GA, Horvath CA,
Vinckx M, Bogers JJ, Van Den Bossche R, Verpooten GA and De Winter
BY: Expression of renal distal tubule transporters TRPM6 and NCC in
a rat model of cyclosporine nephrotoxicity and effect of EGF
treatment. Am J Physiol Renal Physiol. 301:F486–F493. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cai FG, Xiao JS and Ye QF: Effects of
ischemic preconditioning on cyclinD1 expression during early
ischemic reperfusion in rats. World J Gastroenterol. 12:2936–2940.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Rehman MU, Tahir M, Khan AQ, Khan R,
Lateef A, Oday OH, Qamar W, Ali F and Sultana S: Chrysin suppresses
renal carcinogenesis via amelioration of hyperproliferation,
oxidative stress and inflammation: Plausible role of NF-κB. Toxicol
Lett. 216:146–158. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Siddiqi A, Hasan SK, Nafees S, Rashid S,
Saidullah B and Sultana S: Chemopreventive efficacy of hesperidin
against chemically induced nephrotoxicity and renal carcinogenesis
via amelioration of oxidative stress and modulation of multiple
molecular pathways. Exp Mol Pathol. 99:641–653. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Christian F, Smith EL and Carmody RJ: The
regulation of NF-κB subunits by phosphorylation. Cells. 5(pii):
E122016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Perkins ND: Post-translational
modifications regulating the activity and function of the nuclear
factor kappa B pathway. Oncogene. 25:6717–6730. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Espinosa L, Bigas A and Mulero MC: Novel
functions of chromatin-bound IκBα in oncogenic transformation. Br J
Cancer. 111:1688–1692. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cantile M, Schiavo G, Franco R, Cindolo L,
Procino A, D'Armiento M, Facchini G, Terracciano L, Botti G and
Cillo C: Expression of lumbosacral HOX genes, crucial in kidney
organogenesis, is systematically deregulated in clear cell kidney
cancers. Anticancer Drugs. 22:392–401. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Mulero MC, Ferres-Marco D, Islam A,
Margalef P, Pecoraro M, Toll A, Drechsel N, Charneco C, Davis S,
Bellora N, et al: Chromatin-bound IκBα regulates a subset of
polycomb target genes in differentiation and cancer. Cancer Cell.
24:151–166. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Morotti A, Crivellaro S, Panuzzo C, Carrà
G, Guerrasio A and Saglio G: IκB-α: At the crossroad between
oncogenic and tumor-suppressive signals. Oncol Lett. 13:531–534.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Okada K, Wangpoengtrakul C, Osawa T,
Toyokuni S, Tanaka K and Uchida K: 4-Hydroxy-2-nonenal-mediated
impairment of intracellular proteolysis during Oxidative Stress:
Identification of proteasomes as target molecules. J Biol Chem.
274:23787–23793. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhou L and Yang H: The von Hippel-lindau
tumor suppressor protein promotes c-Cbl-independent
poly-ubiquitylation and degradation of the activated EGFR. PLoS
One. 6:e239362011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Johnson AC, Murphy BA, Matelis CM,
Rubinstein Y, Piebenga EC, Akers LM, Neta G, Vinson C and Birrer M:
Activator protein-1 mediates induced but not basal epidermal growth
factor receptor gene expression. Mol Med. 6:17–27. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Brand TM, Iida M, Luthar N, Starr MM,
Huppert EJ and Wheeler DL: Nuclear EGFR as a molecular target in
cancer. Radiother Oncol. 108:370–377. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Sharmila R and Sindhu G: Evaluate the
antigenotoxicity and anticancer role of β-sitosterol by determining
oxidative DNA damage and the expression of phosphorylated
Mitogen-activated Protein Kinases', C-fos, C-jun, and endothelial
growth factor receptor. Pharmacogn Mag. 13:95–101. 2017.PubMed/NCBI
|
|
49
|
Bandyopadhyay D, Mandal M, Adam L,
Mendelsohn J and Kumar R: Physical Interaction between epidermal
growth factor receptor and DNA-dependent protein kinase in
mammalian cells. J Biol Chem. 273:1568–1573. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Goodwin JF and Knudsen KE: Beyond DNA
repair: DNA-PK function in cancer. Cancer Discov. 4:1126–1139.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Liccardi G, Hartley JA and Hochhauser D:
EGFR nuclear translocation modulates DNA repair following cisplatin
and ionizing radiation treatment. Cancer Res. 71:1103–1114. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Toyokuni S, Mori T and Dizdaroglu M: DNA
base modifications in renal chromatin of wistar rats treated with a
renal carcinogen, ferric nitrilotriacetate. Int J Cancer.
57:123–128. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ansar S, Iqbal M and Athar M:
Nordihydroguairetic acid is a potent inhibitor of
ferric-nitrilotriacetate-mediated hepatic and renal toxicity, and
renal tumour promotion, in mice. Carcinogenesis. 20:599–606. 1999.
View Article : Google Scholar : PubMed/NCBI
|
